Cannabinoid Emulsion Compositions for Treating Ophthalmic Conditions

Rhodes Technologies published patent application US20260090988A1 for stable cannabinoid emulsion compositions designed for ocular delivery to treat ophthalmic conditions including glaucoma. The application, filed July 29, 2025, and published April 2, 2026, names inventors Ping Chang, Zhenze Hu, and Yuanyuan Tao. This publication represents a patent application only and does not grant enforceable patent rights.

Aspirin Oral Mucosal Formulations

USPTO published patent application US20260090985A1 for oral mucosal aspirin formulations (91-200mg micronized) with buffer and surfactant components. The application, filed by inventor James Dzandu, covers sublingual and buccal delivery formulations with pH ≤3. No regulatory obligations or compliance deadlines are imposed by this patent publication.

LifeActive Transdermal Delivery Formulations Patent Application

USPTO published patent application US20260090982A1 for LifeActive, Inc., covering transdermal delivery formulations for therapeutic agents, drugs, and nutrients. Inventors include Calvin Dexter Morris, Burgess A. Thomasson Jr., and Scott A. Jenkins. The application discloses homogeneous transdermal formulations combining weak organic acid accelerants with fatty acid microemulsions for enhanced skin absorption.

Urolithin oral care compositions patent application

USPTO published patent application US20260090966A1 for urolithin-based oral care compositions including toothpaste, mouthwash, gels, and chewing gum with therapeutic or cosmetic effects. The application covers compositions comprising urolithins, methods of treatment, and formulations with additional active ingredients such as fluoride. Inventors include Christopher L. Rinsch, Davide D'Amico, Anurag Singh, and Charlotte Tissot.

Cat Food Composition for Treating Urolithiasis and Reducing Hairballs

The USPTO published patent application US20260090571A1 for a cat food composition targeting urolithiasis (urinary stones) and hairball reduction. Inventors Nolan Z. Frantz, Angela M. Gajda, and Todd Harper developed wet and dry formulations incorporating omega-3 sources (flaxseed, fish oil), acidifiers (calcium sulfate, SAPP), methionine, taurine, and dietary fiber to achieve urine pH between 6.15-6.85 and reduce RSS struvite to ≤1.8 and RSS oxalate to ≤6.0.

Cat Food Composition for Treating or Preventing Urolithiasis

The USPTO published patent application US20260090570A1 for a cat food composition designed to treat or prevent urolithiasis (urinary stones) in cats. The wet and dry compositions include omega-3 fatty acids from flaxseed and fish oil, along with pH-modifying ingredients such as calcium sulfate, methionine, sodium acid pyrophosphate, taurine, and potassium sulfate. The application was filed on October 1, 2024, under application number 18903721.

Registrar Court Cause List - Scheduled Insolvency and Company Appeals

The National Company Law Appellate Tribunal (NCLAT) published its daily cause list for the Registrar Court dated April 2, 2026. The list schedules hearings under NCLAT Rule 26(3) for multiple insolvency applications and company appeals at 11:30 AM via hybrid mode. Cases include I.A. Nos. 2340-2344 of 2026 involving parties such as Ebony Estates Private Limited, Amar Kumar Jhunjhunwala, Swati Spentose Private Limited, and Sunil Kumar Trivedi.

NCLAT Court III Supplementary Cause List

NCLAT published its Court III supplementary cause list for April 2, 2026, at 2:00 PM hybrid proceedings. The list includes cases before a three-member bench (Justice N. Seshasayee, Arun Baroka, and Indevar Pandey). Listed matters include I.A. No. 2364 of 2026 involving Greater Noida Industrial Development Authority and No. 322 of 2025 versus Shaurya Shyam. Parties must follow video conferencing protocols for virtual appearances.

Supplementary Cause List - Court II Hearing Schedule

NCLAT Principal Bench released a supplementary cause list for Court-II dated April 2, 2026, scheduled for hybrid video conferencing proceedings. The list covers admission of fresh cases and interim applications including matters involving I.A. No. 2300 of Pawan Kapoor, I.A. No. 2326 of Vijay Kumar Gupta, and Company Petition No. 116 of 2026. Parties are instructed to join the virtual courtroom at 10:30 AM following specified VC protocols.

Daily Cause List - Court of Chairperson Hybrid Mode

NCLAT published its supplementary daily cause list for April 2, 2026, listing company appeals and insolvency matters scheduled for hearing in the Court of Chairperson (Hybrid Mode) at 10:30 AM. The list includes fresh cases for admission, applications after notice, and procedural orders across multiple benches. Parties are directed to appear via video conferencing following published VC protocols.